Supplement × Prescription·a synergy·Emerging evidence

Isoniazid + Milk Thistle

Synergy Emerging evidence

Isoniazid carries a recognized risk of hepatotoxicity. Silymarin from milk thistle has been studied as a hepatoprotective adjunct in patients on antitubercular therapy, with some trials suggesting it may reduce markers of liver injury. Evidence is mixed and milk thistle is not a substitute for standard liver monitoring.

From the database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, and the recommendation.

Substances
Pair type
Synergy
Evidence
Emerging
Source citations
1
Scope
Supplement × Prescription
Last verified
June 4, 2026
SynergyEmerging evidence

What is happening. Isoniazid carries a recognized risk of hepatotoxicity. Silymarin from milk thistle has been studied as a hepatoprotective adjunct in patients on antitubercular therapy, with some trials suggesting it may reduce markers of liver injury. Evidence is mixed and milk thistle is not a substitute for standard liver monitoring.

Mechanism. Silymarin acts as an antioxidant and free-radical scavenger, may stabilize hepatocyte membranes, and supports glutathione status, which could mitigate oxidative hepatocellular stress associated with isoniazid metabolism.

Recommendation. Milk thistle is not a replacement for routine liver function monitoring during isoniazid therapy. If considering it as a hepatoprotective adjunct, discuss with a clinician. Continue scheduled liver enzyme checks and report symptoms such as nausea, dark urine, jaundice, or right upper abdominal pain promptly.

Stack Score

How it moves the number.

Effect on the composite score

If both Isoniazid and Milk Thistle are in the same stack, this pair applies +2 to your Stack Score (per scored synergy row).

The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.

Sources

Sources, by evidence tier.

Every claim on this page is cited. PMIDs link straight to PubMed.

Reference material

1
  • 1Luangchosiri C, et al. A double-blinded randomized controlled trial of silymarin for preventing antituberculosis drug-induced liver injury. BMC Complementary and Alternative Medicine. 2015.Needs sourceNo link

Check your full routine

One pair was the worked example.

Drop your supplements and prescriptions into NutriStack and it runs every pair at once: every interaction, synergy, timing rule, and contraindication, each linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.